Related Targets |
Mechanism CD4 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date06 Mar 2018 |
Mechanism CD4 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date28 Nov 2023 |
Sponsor / Collaborator |
Start Date05 Aug 2022 |
Sponsor / Collaborator [+1] |